Margaretha A Skowron (M A Skowron)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Induced Apoptosis

Dna Damage Response

Top Venues

Molecular medicine (Cambridge, Mass.)

Molecular oncology

Scientific reports

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Söhngen, David J Thomas, Margaretha A Skowron, Felix Bremmer, Markus Eckstein, Anja Stefanski, Marc D Driessen, Gamal A Wakileh, Kai Stühler, Peter Altevogt, Dan Theodorescu, Rüdiger Klapdor, Axel Schambach, Daniel Nettersheim
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners. The FEBS journal (2023)
Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Margaretha A Skowron, Mara Kotthoff, Felix Bremmer, Katja Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter-Jessen, Stella Pauls, Anja Stefanski, Philipp Ströbel, Kai Stühler, Daniel Nettersheim
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, Melanie R Müller, Andrea Seiwert, Stefan Höfmann, Fabian Fischer, Hector Torres-Gomez, Michèle Janine Hoffmann, Guenter Niegisch, Felix Bremmer, Patrick Petzsch, Karl Köhrer, Peter Albers, Thomas Kurz, Margaretha A Skowron, Daniel Nettersheim
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. Molecular cancer therapeutics 21 (11) (2022)
Margaretha A Skowron, Katharina Eul, Alexa Stephan, Gillian F Ludwig, Gamal A Wakileh, Arthur Bister, Christian Söhngen, Katharina Raba, Patrick Petzsch, Gereon Poschmann, Edmund Osei Kuffour, Daniel Degrandi, Shafaqat Ali, Constanze Wiek, Helmut Hanenberg, Carsten Münk, Kai Stühler, Karl Köhrer, Elvira Mass, Daniel Nettersheim
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level. Molecular oncology 16 (17) (2022)
Lena Berning, David Schlütermann, Annabelle Friedrich, Niklas Berleth, Yadong Sun, Wenxian Wu, María José Mendiburo, Jana Deitersen, Hannah U C Brass, Margaretha A Skowron, Michèle Janine Hoffmann, Guenter Niegisch, Jörg Pietruszka, Björn Stork
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules (Basel, Switzerland) 26 (5) (2021)
Wasco Wruck, Felix Bremmer, Mara Kotthoff, Alexander Fichtner, Margaretha A Skowron, Stefan Schönberger, Gabriele Calaminus, Christian Vokuhl, David Pfister, Axel Heidenreich, Peter Albers, James Adjaye, Daniel Nettersheim
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours. Journal of cellular and molecular medicine 25 (3) (2021)
Margaretha A Skowron, Teresa K Becker, Lukas Kurz, Sina Jostes, Felix Bremmer, Florian Fronhoffs, Kai Funke, Gamal A Wakileh, Melanie R Müller, Aaron Burmeister, Thomas Lenz, Anja Stefanski, Kai Stühler, Patrick Petzsch, Karl Köhrer, Peter Altevogt, Peter Albers, Glen Kristiansen, Hubert Schorle, Daniel Nettersheim
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. Molecular oncology (2021)
Margaretha A Skowron, Patrick Petzsch, Karin Hardt, Nicholas Wagner, Manfred Beier, Stefanie Thom, Matthias Drechsler, Harald Rieder, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann, Wolfgang A Schulz
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines. Scientific reports 9 (1) (2019)
Christoph Oing, Margaretha A Skowron, C Bokemeyer, Daniel Nettersheim
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations. Andrology 7 (4) (2019)
Margaretha A Skowron, Margarita Melnikova, Joep G H van Roermund, Andrea Romano, Peter Albers, Juergen Thomale, Wolfgang A Schulz, Guenter Niegisch, Michèle J Hoffmann
Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines. International journal of molecular sciences 19 (2) (2018)